Download by
Scanning QR Code
No Data
US Stock MarketDetailed Quotes
CDMO Avid Bioservices
Watchlist
9.560
+0.370+4.03% Close 10/03 16:00 ET
9.5600.0000.00%
Post 16:03 ET
9.610High9.040Low421.30KVolume
9.120Open9.190Pre Close4.00MTurnover0.72%Turnover RatioLossP/E (TTM)603.36MMarket Cap21.05052wk High956.00P/E (Static)63.11MShares9.03052wk Low3.17P/B563.11MFloat Cap116.375Historical High--Dividend TTM58.90MShs Float1.540Historical Low--Div YieldTTM6.20%Amplitude9.498Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Avid Bioservices Company
Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. It focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
News
William Blair Initiates Coverage on Avid Bioservices With Market Perform Rating
Avid Bioservices (CDMO) has an average buy rating and price target range of $15 to $22, according to analysts polled by Capital IQ.
Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference
Insider Spends US$191k Buying More Shares In Avid Bioservices
Investors who take an interest in Avid Bioservices, Inc. (NASDAQ:CDMO) should definitely note that the Independent Chairman, Joseph Carleone, recently paid US$9.53 per share to buy US$191k worth of th